Biometals DOI 10.1007/s10534-016-9911-y
Zinc supplementation ameliorates glycoprotein components and oxidative stress changes in the lung of streptozotocin diabetic rats Ozlem Sacan . Ismet Burcu Turkyilmaz . Bertan Boran Bayrak . Ozgur Mutlu . Nuriye Akev . Refiye Yanardag
Received: 3 September 2015 / Accepted: 15 January 2016 Springer Science+Business Media New York 2016
Abstract Zinc (Zn) is a component of numerous enzymes that function in a wide range of biological process, including growth, development, immunity and intermediary metabolism. Zn may play a role in chronic states such as cardiovascular disease and diabetes mellitus. Zn acts as cofactor and for many enzymes and proteins and has antioxidant, antiinflammatory and antiapoptotic effects. Taking into consideration that lung is a possible target organ for diabetic complications, the aim of this study was to investigate the protective role of zinc on the glycoprotein content and antioxidant enzyme activities of streptozotocin (STZ) induced diabetic rat tissues. Female Swiss albino rats were divided into four groups. Group I, control; Group II, control ? zinc sulfate; Group III, STZ-diabetic; Group IV, diabetic ? zinc sulfate. Diabetes was induced by intraperitoneal injection of STZ (65 mg/kg body weight). Zinc sulfate was given daily by gavage at a dose of 100 mg/kg body weight every day for 60 days to groups II and IV. At the last day of the experiment, rats were sacrificed, lung tissues were
taken. Also, glycoprotein components, tissue factor (TF) activity, protein carbonyl (PC), advanced oxidative protein products (AOPP), hydroxyproline, and enzyme activities in lung tissues were determined. Glycoprotein components, TF activity, lipid peroxidation, non enzymatic glycation, PC, AOPP, hydroxyl proline, lactate dehydrogenase, catalase, superoxide dismutase, myeloperoxidase, xanthine oxidase, adenosine deaminase and prolidase significantly increased in lung tissues of diabetic rats. Also, glutathione levels, paraoxonase, arylesterase, carbonic anhydrase, and Na?/K?- ATPase activities were decreased. Administration of zinc significantly reversed these effects. Thus, the study indicates that zinc possesses a significantly beneficial effect on the glycoprotein components and oxidant/antioxidant enzyme activities. Keywords Zinc Diabetes mellitus Lung Glycoprotein Oxidative stress
Introduction O. Sacan I. B. Turkyilmaz B. B. Bayrak O. Mutlu R. Yanardag (&) Department of Chemistry, Faculty of Engineering, Istanbul University, 34320 Avcilar/Istanbul, Turkey e-mail: [email protected] N. Akev Department of Biochemistry, Faculty of Pharmacy, Istanbul University, 34116 Istanbul, Turkey
Diabetes mellitus (DM) is a clinical syndrome associated with oxidative stress and is a major cause of serious micro and macrovascular diseases that affect nearly every system in the body, including respiratory system. Lung is a target organ in diabetic patients (Marvisi et al. 2001). Diabetic patients are at increased risk of several pulmonary complications such as
123
Biometals
asthma, inflammatory infectious diseases and chronic obstructive pulmonary disease (American Diabetes Association 2010). Glycoproteins are rich in extracellular matrix, and they contribute as a major source to matrix structure (Wiese et al. 1997). These groups of macromolecules carry out numerous biological functions including vitamins and lipid transport, hemoglobin binding, play role in signal transduction as hormone receptors, and immunological specifity and blood coagulation. Raised levels of glycoproteins in diabetics may also be a predictor of angiopathic complications (Konukoglu et al. 1999). Hyperglycemia mediated oxidative stress and inflammation plays a major role in the development of diabetic complications and tissue injury. Reactive oxygen species (ROS) have also been proposed to be involved in many serious diseases. In diabetes, oxidative stress that is caused by excess ROS is symmetrically increased, because high glucose levels generate ROS in a variety of cell types (Maritim et al. 2003). It has been reported that diabetes induces alterations in the activities of antioxidant enzymes in various tissues (Oberley 1988). Several trace elements are involved in glucose metabolism. Zn is an essential mineral that is required for various cellular functions. Zn deficiency has been shown to play a role of multiple diseases, such as malabsorption syndrome, sickle cell disease, chronic liver disease, hypogonadism, dermatitis, teratogeny and diabetes (Prasad 1993). In the case of diabetes, zinc is considered important mainly because it plays a major role in the stabilization of insulin hexamers and the pancreatic storage of the hormone (Wijesekara et al. 2009). Zn was reported to improve glycemia, and to restore zinc status in patients (Marjani et al. 2005) or animals (Ozsoy et al. 2012) with type-2 diabetes, by counteracting the deleterious effects of oxidative stress and thus helps to prevent complications associated with the disease. Zn may act by different protection mechanisms, as cofactor for many enzymes and proteins and may play a critical role as a potent anti-oxidant and anti-inflammatory agent (Hennig et al. 1999; Prasad et al. 2004; Prasad 2008; Jansen et al. 2009). As an antioxidant, Zn act by two different mechanisms: In the first mechanism, Zn protects sulfhydryl groups against oxidation. In the second mechanism, it inhibits production of ROS. The aim of this study was to investigate the protective role of Zn in streptozotocin—(STZ)
123
induced diabetic lung tissues and try to elucidate its mechanism of action through the changes in the content of glycoprotein components and the activities of several enzymes.
Biochemical estimations Animals Female, 6–6.5 months old, clinically healthy Swiss albino rats were used. The rats were randomly divided into four groups. Experimental design Group I: control (untreated) animals; Group II: control animals given zinc sulfate: Group III: diabetic animals; Diabetes was induced by intraperitoneal injection of streptozotocin (STZ) in a single dose of 65 mg/kg. STZ was dissolved in a freshly prepared 0.01 M pH 4.5 citrate buffer. Blood glucose levels over 200 mg/dL were considered as diabetic and taken into the diabetic group (Bolkent et al. 2009). Group IV: diabetic animals given zinc sulfate. Zinc sulfate was given to groups II and IV by gavage at a dose of 100 mg/kg body weight, every day, for 60 days. The ZnSO4 solution was given to IV groups after the induction of diabetes. The animals were fasted overnight prior to experiment, but they were allowed free access to water. At the last day of the experiment, lung tissue was taken from animals. In this study, biochemical investigations were undertaken in lung tissue from all groups. For biochemical analyses, the tissue samples were washed with saline and kept frozen until the day of the experiment. These tissue samples were homogenized in cold 0.9 % NaCl with a glass homogenizer to make up 10 % (w/v) homogenate. The homogenates were centrifuged. The supernatant fraction was removed for the determination of glycoprotein components, glutathione (GSH), lipid peroxidation (LPO), nonenzymatic glycations (NEG), advanced oxidation protein products (AOPP), protein carbonyl (PC), hydroxyproline (OH-proline) and protein levels and enzyme activities. Hexose and hexosamine levels were determined according to Winzler’s method (1955). Fucose levels in lung homogenates were estimated by Dische and Shettles’s method (1948). Lung tissue sialic acid was assessed by the Lorenz et al. method (1986). Tissue
Biometals
factor (TF) activity of lung tissue was evaluated according to Quick’s one-stage method using normal plasma (Ingram and Hills 1976). GSH and LPO levels were evaluated by the method described by Beutler (1975) and Ledwozyw et al. (1986) respectively. Parker et al. (1981) method was used to analyse the lung NEG. PC and AOPP levels were measured by the method of Levine et al. (1990) and Witko-Sarsat et al. (1996). Lung OH-proline levels were assayed by the method of Reedy and Enwemeka (1996). Catalase (CAT) activity was assayed in lung tissues by the method of Aebi (1984). Lung superoxide dismutase (SOD) activity was assayed by the method described by Mylorie et al. (1986). Glutathione peroxidase (GPx) activity was determined by the method described by Paglia and Valentine (1967) and modified by Wendel (1981). Myeloperoxidase (MPO) activity was determined by the method described Wei and Frenkel (1991). Lactate dehydrogenase (LDH) activity was determined by the method of Wroblewski (1957). Furlong et al. (1988) method was used to analyse the lung tissue paraoxanase activity. Arylesterase (ARE) activity was done by the method of Gan et al. (1991). Carbonic anhydrase (CA) activity was assayed by the method described by Verpoorte et al. (1967). Sodium potassium ATPase (Na?/K?-ATPase) activity was determined by the method of Ridderstap and Bonting (1969). Lung prolidase activity was determined by the method described Chinard (1952). Karker (1964) and Corte and Stirpe (1968) methods were used to analyse
the lung adenosine deaminase (ADA) and xanthine oxidase (XO) activities. The protein content was estimated by the method of Lowry using bovine serum albumin as standard (Lowry et al. 1951). Statistical analysis Biochemical results were analysed by two-way ANOVA and Mann–Whitney U test by using GraphPad Prism version 4.0 computer package. Results were reported as mean ± SD. P values less than 0.05 were considered to be significant.
Results Table 1 shows the changes in the level of tissue glycoprotein components and TF activity of control and experimental rats. The levels of glycoproteins containing hexose, hexosamine, fucose and sialic acid (P \ 0.005, P \ 0.0001 and P \ 0.005, respectively) were significantly increased whereas TF activity was significantly decreased (P \ 0.05) in the diabetic group. Administration of Zn significantly reversed these changes in glycoprotein components (P \ 0.001, P \ 0.0001, P \ 0.005 and P \ 0.0001 respectively) and TF activity (P \ 0.005) in the lung of diabetic rats (Table 1). GSH, LPO, NEG, PC, AOPP and OH-proline levels are presented in Table 2. A significant decrease was observed in lung tissue GSH levels in STZ-diabetic
Table 1 Lung tissue hexose, hexosamine, fucose, sialic acid and tissue factor (TF) levels of all groups Group
Hexose (mg glucose/mg protein)*
Hexosamine (lg glucosamine/mg protein)*
Fucose (lg fucose/mg protein)*
Sialic Acid (lmole sialic acid/g protein)*
TF (Sec)*
Control
3.45 ± 0.30
7.65 ± 0.56
7.62 ± 0.94
147.18 ± 5.82
229.67 ± 22.81
Control ? Zn
3.11 ± 0.11
5.33 ± 0.71
4.45 ± 0.54
164.86 ± 7.07
270.25 ± 16.82
Diabetic
9.41 ± 1.56a
41.59 ± 2.53c
14.16 ± 2.15a
276.14 ± 14.00a
186.80 ± 8.79f
Diabetic ? Zn
4.75 ± 0.55b
15.55 ± 1.78d
2.39 ± 0.14e
162.06 ± 8.22d
233.50 ± 4.95e
* Mean ± SD a
P \ 0.005 versus control group
b
P \ 0.001 versus diabetic group
c
P \ 0.0001 versus control group
d
P \ 0.0001 versus diabetic group
e
P \ 0.005 versus diabetic group
f
P \ 0.05 versus control group
123
Biometals Table 2 Lung GSH, LPO, NEG, PC, AOPP and OH-proline levels of all groups Group
Control Control ? Zn Diabetic Diabetic ? Zn
GSH (nmol GSH/mg protein) *
LPO (nmol MDA/mg protein)*
NEG (nmol fructose/mg protein)*
PC (nmol carbonyl/mg protein)*
AOPP (pmol/mg protein)*
OH-Proline (lg/g tissue)*
9.92 ± 1.25
0.67 ± 0.09
6.39 ± 1.03
14.18 ± 2.25
7.79 ± 1.03
12.27 ± 1.32a
0.86 ± 0.11a
10.86 ± 0.88e
23.18 ± 3.85a
4.88 ± 0.76
5.03 ± 1.65b
1.30 ± 0.41b
24.27 ± 5.42f
65.25 ± 6.21b
10.96 ± 1.30a
81.45 ± 3.24a
13.09 ± 2.61c
0.90 ± 0.10d
17.01 ± 2.02
21.70 ± 2.85c
6.40 ± 0.56d
73.90 ± 1.95
g
68.43 ± 8.50 h
71.37 ± 7.67 g
* Mean ± SD a
P \ 0.05 versus control group
b
P \ 0.0001 versus control group
c
P \ 0.0001 versus diabetic group
d
P \ 0.001 versus diabetic group
e
P \ 0.0001 versus control group
f
P \ 0.001 versus control group
g
P \ 0.05 versus diabetic group
h
P \ 0.005 versus control group
rats (P \ 0.0001). LPO, NEG, PC, AOPP and OHproline levels were significantly increased in STZdiabetic rats (P \ 0.0001, P \ 0.001, P \ 0.0001 and P \ 0.05, respectively). Administration of Zn significantly decreased the levels of these parameters (P \ 0.0001, P \ 0.001, P \ 0.05, P \ 0.0001, P \ 0.001 and P \ 0.05, respectively) (Table 2). The LDH, CAT, SOD, GPx and MPO activities in the lung tissue are presented in Table 3. Lung LDH, CAT, SOD, GPx and MPO activities were significantly increased in STZ-diabetic rats (P \ 0.0001, P \ 0.001 and P \ 0.0001, respectively). Zn treatment caused a significant decrease in the activities of these enzymes (P \ 0.0001, P \ 0.0001, P \ 0.0001, P \ 0.05 and P \ 0.0001 respectively) (Table 3). The paraoxonase, ARE, XO and ADA activities in the lung tissue are presented in Table 4. Lung paraoxonase and ARE activities were significantly decreased (P \ 0.0001 and P \ 0.005 respectively), while lung XO and ADA activities were significantly increased in diabetic rats (P \ 0.01 and P \ 0.05 respectively). Treatment with Zn reversed these changes (P \ 0.0001, P \ 0.05 and P \ 0.005, respectively) (Table 4). The CA, Na?/K?- ATPase and prolidase activities in the lung tissue are shown in Table 5. Lung CA and Na?/K?-ATPase activities were significantly decreased in diabetic group compared to control group (P \ 0.0001 respectively). A significant reduction in
123
CA and Na?/K?-ATPase activities was also seen in the control group given Zn (P \ 0.0001, P \ 0.05 respectively). Administration of Zn significantly increased CA and Na?/K?-ATPase activities in diabetic group (P \ 0.0001, respectively). Prolidase activity in lung tissue was significantly increased in diabetic group compared to control group (P \ 0.0001). However, treatment with Zn significantly decreased prolidase activity in diabetic group (P \ 0.0001) (Table 5).
Discussion Diabetes mellitus is a serious metabolic disorder with micro and macrovascular complications that results in significant morbidity and mortality. Metal ions are known to play an essential role in living systems both in growth and in metabolism. DM is associated with hyperglycemia and with accelerated non-enzymatic glycation, increased oxidative stress and free radical production. Hyperglycemia causes local biochemical in changes in lungs resulting in reduced antioxidant defense. Abnormalities of glycoprotein metabolism are commonly observed both naturally and experimental diabetes (Kumar et al. 2005; Pari and Ashokkumar 2006). Insulin deficiency and high levels of serum glucose may result in an increased synthesis of
Biometals Table 3 Lung LDH, CAT, SOD, GPx and MPO activities of all groups Group
LDH (U/mg protein) *
CAT (U/mg protein)*
SOD (U/g protein)*
GPX (U/g protein)*
MPO (mU/g tissue)*
Control
390.44 ± 26.88
23.71 ± 6.92
15.39 ± 1.87
26.13 ± 0.22
Control ? Zn
145.75 ± 13.49a
49.23 ± 1.49c
14.01 ± 0.23
10.00 ± 2.40a
2.62 ± 0.28f
a
14.84 ± 1.39a 5.65 ± 0.95b
Diabetic Diabetic ? Zn
579.12 ± 34.83 156.89 ± 9.76b
a
d
105.22 ± 13.27 13.30 ± 0.78b
a
26.77 ± 2.20 14.66 ± 0.57b
3.39 ± 0.70
6.86 ± 0.78 9.91 ± 0.39e
* Mean ± SD a
P \ 0.0001 versus control group
b
P \ 0.0001 versus diabetic group
c
P \ 0.005 versus control group
d
P \ 0.001 versus control group
e
P \ 0.05 versus diabetic group
f
P \ 0.05 versus control group
Table 4 Lung paraoxonase, ARE, XO and ADA activities of all groups Group
Paraoxonase (U/g protein)*
ARE (kU/g protein)*
XO (U/mg protein)*
ADA (U/g protein)*
Control
16.41 ± 3.34
5.38 ± 0.63
0.17 ± 0.03
86.78 ± 4.94
Control ? Zn
13.42 ± 0.43a
5.42 ± 0.58
0.12 ± 0.02a
88.12 ± 10.22
6.74 ± 0.82b
3.67 ± 0.46d
0.25 ± 0.02f
97.14 ± 4.03a
18.77 ± 2.49c
5.82 ± 0.25e
0.15 ± 0.04
Diabetic Diabetic ? Zn
g
61.27 ± 8.85
g
* Mean ± SD a
P \ 0.05 versus control group
b
P \ 0.0001 versus control group
c
P \ 0.0001 versus diabetic group
d
P \ 0.005 versus control group
e
P \ 0.05 versus diabetic group
f
P \ 0.01 versus control group
g
P \ 0.005 versus diabetic group
Table 5 Lung CA, Na?/K?- ATPase, prolidase activities of all groups Group
CA (U/mg protein)*
Na?/K?- ATPase (nmol P/mg protein/h)*
Control
49.21 ± 3.15
11.65 ± 1.05
Control ? Zn Diabetic Diabetic ? Zn
a
27.00 ± 1.06
a
15.08 ± 1.49
b
21.13 ± 1.31
Prolidase (U/g protein)* 66.80 ± 4.11
c
32.07 ± 1.79a
a
102.63 ± 5.08a
b
41.03 ± 4.24b
6.09 ± 0.36 1.74 ± 0.02 3.24 ± 0.45
* Mean ± SD a
P \ 0.0001 versus control group
b
P \ 0.0001 versus diabetic group
c
P \ 0.05 versus control group
123
Biometals
glycoprotein components such as hexose, hexosamine, fucose and sialic acid (Patti et al. 1999). In this study, we have observed increased levels of hexose, hexosamine, fucose and sialic acid in the lung tissue of STZ diabetic rats. Glycoproteins contribute as a major source to the structure of the matrix, they have multiple and complex functions as enzymes, hormones, blood group substances and as constituents of extracellular membranes (Muruganathan et al. 2013). In this study, Zn treatment in diabetic rats reversed the alterations in the glycoprotein components towards near normal levels. This shows that Zn can normalize the glycoprotein metabolism which is altered in diabetes. Decreased hyperglycemic state with treatment Zn in diabetic rats might be responsible for the beneficial changes in glycoprotein in lung. Our results were in agreement with the results of Sulaiman et al. (2012) and Muruganathan et al. (2013). TF is considered to be a major regulator of normal haemostasis and thrombosis (Rauch and Nemerson 2000). TF is involved in the pathophysiology of systemic inflammatory disorders, coagulopathies and tumor angiogenesis. TF activity is also suggested to be a marker associated with DM (Emekli-Alturfan et al. 2007). Various tissues and body fluids such as lung, brain, testis, heart, kidney and aorta have been known to have TF activity (Emekli-Alturfan et al. 2007). The lung tissue had the highest TF activity. In the present study, TF activity was increased in diabetic lung tissue. Treatment with Zn significantly decreased the TF activity in diabetic rats. This decrease may be due to the antiinflammatory effect of Zn. This restoration in TF activity in diabetic group given Zn, might protect lung tissue from the risk of thrombosis. Accordingly, Emekli-Alturfan et al. (2007) have shown that TF activity is increased in the lung of diabetic rats. Elevation of free radical levels can in turn lead to increased lipid peroxidation and decreased levels of GSH. In the present study, LPO levels (expressed as MDA) in DM group were found to be significantly higher than in the control group in lung tissue. Zn significantly decreased MDA production. Additionally Zn significantly increased GSH levels. LPO increase leads to the release of lysosomal and mitochondrial matrix proteolytic enzymes into the cytoplasm. Similar results were reported in diabetic animals (Tunali and Yanardag 2013; Gezginci-Oktayoglu et al. 2014). Several studies reported the effect
123
of Zn in reducing diabetes and its antioxidant property (Ozsoy et al. 2012; Karatug et al. 2013). Thus we can postulate like Vallee and Falchuk (1993) that Zn may play a role in protecting the cell from oxidative stress by decreasing LPO. NEG may increase due to increased oxidative stress. In this study, NEG levels were found to increase in diabetic rats. In our previous studies, we have demonstrated that NEG level were increased in diabetic rats (Yanardag and Tunali 2006). It has been reported that various plant extracts, vitamins and some transition metals prevent the increase of tissue NEG levels in diabetic rats (Gezginci-Oktayoglu et al. 2009). In this study, NEG levels which were increased in diabetic rat lung tissue, were decreased with the administration of Zn. NEG results support the fact that administration of Zn is able to reduce the oxidative stress in diabetic animals. PC levels are routinely used as a biomarker for protein damage caused by oxidized amino acid residues in stress conditions. In our study PC levels were significantly higher in diabetic rats. Several studies have reported increased levels of PC in diabetic animals (Karatug et al. 2012). Our data are in agreement with other research and confirm the presence of increased oxidative damage in DM (Gezginci-Oktayoglu et al. 2011, 2014). In this study, Zn treatment to diabetic rats reversed the increase in PC levels by the regression of oxidative stress through their antioxidant and hypoglycemic properties. AOPP are another marker that indicates oxidative stress-based protein damage (Kanth et al. 2008). Some authors have reported the elevation of AOPP in diabetic patients (Baskol et al. 2008; Brzovic´-Sˇaric´ et al. 2015). In our study, AOPP levels were increased in diabetic lung tissues. Also, Zn treatment to diabetic rats reversed this increase. This result indicated that Zn may be effective in preventing oxidative protein damage. Hydroxyproline content is commonly used as an indicator of the amount of collagen in wound tissue. In the present study, the hydroxyproline levels were significantly increased in diabetic rats indicating the negative destructive of diabetes on lung collagen. This result is consistent with that of the previous study (Gopalakrishnan et al. 2006). Zn administration reverse this increase showing the restoration of collagen damage. LDH is a terminal glycolytic enzyme that plays an indispensable role in the interconversion pyruvate to
Biometals
lactate to yield energy under anaerobic conditions. LDH activity is altered by insulin, glucose and NADH. Increased LDH activity in diabetic rats and patients is associated with impaired glucose stimulated insulin secretion (Shulman 2000). Similarly in our study, there was an increase in activity of LDH in the lung of diabetic animals. Administration of Zn restored LDH activity to normal level. Endogenous antioxidant enzymes CAT and SOD are responsible for the detoxification of deleterious oxygen radicals and play an important role in protecting cell form oxidative damage. In the present study, we have observed an increase in the activities of CAT and SOD in the lung tissue of diabetic rats. The increase in CAT activity in lung tissue may indicate a high degree of oxidative stress resulting in the increased endogenous H2O2. In the present study, the increased SOD activity may be another sign for the oxidative stress in the lung tissue. Zn might be a scavenger for the free radicals. Therefore, it might prevent the elevation of the activities of CAT and SOD in diabetic rat lung. Plasma and tissue MPO activity is valuable marker of chronic inflammation which is common in type 1 diabetes patients (Tran et al. 2012). Accordingly, in this study, MPO activity increased in the lung tissue of diabetic rats. Treatment with Zn significantly reduced the MPO activities of diabetic rats. We suggest that Zn decreases MPO-induced ROS generation and consequently may reduce lung damage in diabetic rats. PON1 is a calcium dependent enzyme. PON1 has three known enzymatic molecules including paraoxonase, arylesterase and dyazoxonase. PON1 activity has been linked to a variety of human conditions and diseases such as inflammation, myocardial infarction, stroke, Alzheimer’s and diabetes (Camps et al. 2009). Decreased PON1 activity may be in response to inflammation in patients with diabetes and cancer (Devarajan et al. 2014). Various researchers reported that PON1 activity decreased in patients with type 1 and 2 diabetes (Ikeda et al. 1998; Mackness et al. 2000). Accordingly, in the present study, PON1 and arylesterase activities were reduced in the STZ diabetic rats. Decreased PON1 and arylesterase activities in diabetic rats might be related to hyperglycemia and oxidative stress. Lung paraoxonase and arylesterase activities were increased in diabetes ?Zn group and might be related to the direct stimulating effect of Zn on PON 1 and arylesterase or to its antioxidant properties.
In the current study, XO activity was increased in DM group when compared with the control group. Zinc also significantly decreased XO activity. XO can act as an important biological source of ROS. According to a previous study, tissue XO activity is increased in experimental diabetes and this contributes to superoxide production (Matsumoto et al. 2003). Increased XO activities in diabetic rats may lead to enhanced oxidative stress in the lung, leading to secondary organ damage associated with diabetes. Treatment with Zn significantly protected the lung against XO-derived ROS formation via pathways of XO inhibition in hyperglycemic rats. ADA is suggested to be an important enzyme for modulating the bioactivity of insulin (Hoshino et al. 1994). Rutkiewicz and Go´rski (1990) has shown an increase in ADA activity in tissues of STZ induced diabetic rats. Similarly, in another study conducted by us, ADA activity increased in diabetic liver tissue and chard, inhibited ADA activity and reduced glucose levels in hyperglycemic rats (Gezginci-Oktayoglu et al. 2014). The results of the present study demonstrated that ADA activity was increased in diabetic lung tissue. Zn treatment to diabetic rats reversed this increase. The activity of CA in various diseases has been studied and different changes in CA activity have been associated with an altered metabolism in DM. Several studies showed that CA activity was directly proportional with increasing blood glucose concentration (Shah et al. 2013; Biswas and Kumar 2012). Parui et al. (1992) showed that erythrocyte receptor-bound insulin increased CA activity and, Abel et al. (1997) reported lower CA activity in type I diabetic patients. The fact that Zn is the cofactor of CA could be the reason of the decrease of activity in the control group given Zn, due to feed-back mechanism. Nevertheless the significant decrease in CA activity seen in the diabetic group was restored by administration on zinc to the control ? zinc sulphate group’s levels. Na?/K?- ATPase, are enzymes located in the cell membrane responsible for the active transport of various ions, and are highly sensitive to free radical reactions. These enzymes are very susceptible to structural changes due to lipid peroxidation (Rodrigo et al. 2002). For this reason, Na?/K?- ATPase activity can be used as an index for the degree of LPO (Koksel et al. 2004). A decrease of Na?/K?- ATPase can indicate membrane injury (Ariciog˘lu et al. 1994). Decreased lung Na?/K?- ATPase activity may result
123
Biometals
in the loss of physiologic function of lung tissue. In our study, Na?/K?- ATPase decreased in STZ diabetic rats. Similarly, Pinter et al. (1991) indicated a decrease in lung Na?/K?- ATPase activity in STZ-treated rats. Treatment with zinc significantly increased the Na?/ K?- ATPase activity. Zn might have prevented the inhibition of Na?/K?- ATPase by means of detoxification of reactive oxygen radicals. In diabetic patients and animals, high blood glucose levels may delay proliferation of cells and decrease collagen production. Furthermore, prolidase may increase breakdown of collagen (Araki et al. 2010; Bradley et al. 2000). The changing in prolidase enzyme activity is associated with this recycling of proline. The degree of oxidative stress is related to the inhibition of collagen production. In the present study, we have investigated the activity of prolidase activity and hydroxyproline levels in diabetic rats with the idea that might be related to collagen breakdown in the pathogenesis of DM. In our study, we have found that lung prolidase activity was significantly higher in diabetic rats than in controls. The increase in prolidase activity is considered to be correlated with the increased intensity of collagen breakdown. In addition, we found that lung hydroxyproline levels were significantly higher in diabetic groups. Treatment with zinc reduced the prolidase activity and hydroxyproline levels to similar levels of controls. These findings can support a relationship between the pathogenesis of diabetes mellitus and collagen turnover. Trace element metabolism has been reported to possess specific roles in the pathogenesis and progress of diabetes mellitus (Badran et al. 2016). Early reports indicate that zinc has antioxidant, antidiabetic and anti-inflammatory effects (Prasad 2008, 2014). The breaking down of glycoprotein levels and enzyme activities in STZ-diabetic rats were shown in some studies (Punithavathi et al. 2011; Sundaram et al. 2012; Muruganathan et al. 2013). In our study, it was observed that administration of Zn repaired these activities in STZ-diabetic rats. As a result, we can postulate that zinc has a protective effect in diabetic lung tissue probably through activation of enzymes related to oxidative stress, anti-inflammatory mechanism and reduction of collagen injury. Acknowledgments This work was supported by Istanbul University Scientific Research Projects. Project Number: UDP37282.
123
References Abel P, Wussow S, Blu¨cher H, Gros G, Retting R, Honig A (1997) Erythrocyte carbonic anhydrase activity in smokers and diabetic patients. Exp Clin Endocrinol Diabetes 105:17–19 Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126 American Diabetes Association (2010) Standards of medical care in diabetes-2010. Diabetes Care 33:S11–S61 Araki S, Haneda M, Koya D, Isshiki K, Kume S, Sugimoto T, Kawai H, Nishio Y, Kashiwagi A, Uzu T, Maegawa H (2010) Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria. Diabetes Care 33:1805–1810 Ariciog˘lu A, Aydin S, Turkozkan N, Durmus O (1994) The effect of allopurinol on Na ? K ? ATPase related lipid peroxidation in ischemic and reperfused rabbit kidney. Gen Pharmacol 25:341–344 Badran M, Morsy R, Soliman H, Elnimr T (2016) Assessment of trace elements levels in patients with Type 2 diabetes using multivariate statistical analysis. J Trace Elem Med Biol 33:114–119 Baskol G, Gumus K, Oner A, Arda H, Karakucuk S (2008) The role of advanced oxidation protein products and total thiols in diabetic retinopathy. Eur J Ophthalmol 18:792–798 Beutler E (1975) Red cell metabolism. A manual of biochemical methods, 2nd edn. Grune and Stratton, New York, pp 112–114 Biswas UK, Kumar A (2012) Study on the changes of carbonic anhydrase activity in insulin resistance and the effect of methylglyoxal. J Pak Med Assoc 62:417–421 Bolkent S, Yanardag R, Bolkent S, Mutlu O (2009) The influence of zinc supplementation on the pancreas of streptozotocin-diabetic rats. Dig Dis Sci 54:2583–2587 Bradley JL, King RH, Muddle JR, Thomas PK (2000) The extracellular matrix of peripheral nerve in diabetic polyneuropathy. Acta Neuropathol 99:539–546 Brzovic´-Sˇaric´ V, Landeka I, Sˇaric´ B, Barberic´ M, Andrijasˇevic´ L, Cerovski B, Orsˇolic´ N, Ðikic´ D (2015) Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients. Mol Vis 21:649–664 Camps J, Marsillach J, Joven J (2009) The paroxanases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci 46:83–106 Chinard FP (1952) Photometric estimation of proline and ornithine. J Biol Chem 199:91–95 Corte ED, Stirpe F (1968) Regulation of xanthine oxidase in rat liver: modifications of the enzyme activity of rat liver supernatant on the storage at 20 degrees. Biochem J 108:349–351 Devarajan A, Shih D, Sirinivasa TR (2014) Inflammation, infection, cancer and all that…the role of paraoxonases. Adv Exp Med Biol 824:33–41 Dische Z, Shettles LB (1948) A specific color reaction of methylpentoses and a spectrophotometric micromethod for their determination. J Biol Chem 175:595–603 Emekli-Alturfan E, Kasikci E, Yarat A (2007) Tissue factor activities of streptozotocin induced diabetic rat tissues and
Biometals the effect of peanut consumption. Diabetes/Metab Res Rev 23:653–658 Furlong CE, Richter RJ, Seidel SL, Motulsky AG (1988) Role of genetic polymorphism of human plasma paraoxonase/ arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon. Am J Hum Genet 43:230–238 Gan KN, Smolen A, Eckerson HW, La Du BN (1991) Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 19:100–106 Gezginci-Oktayoglu S, Basaraner H, Yanardag R, Bolkent S (2009) The effects of combined treatment of antioxidants on the liver injury in STZ diabetic rats. Dig Dis Sci 54:538–546 Gezginci-Oktayoglu S, Sacan O, Yanardag R, Karatug A, Bolkent S (2011) Exendin-4 improves hepatocyte injury by decreasing proliferation through blocking NGF/TrkA in diabetic mice. Peptides 32:223–231 Gezginci-Oktayoglu S, Sacan O, Bolkent S, Ipci Y, Kabasakal L, Sener G, Yanardag R (2014) Chard (Beta vulgaris L. var. cicla) extract ameliorates hyperglycemia by increasing GLUT2 through Akt2 and antioxidant defense in the liver of rats. Acta Histochem 116:32–39 Gopalakrishnan V, Arunakaran J, Aruldhas MM, Srinivasan N (2006) Effects of streptozotocin-induced diabetes mellitus on some bone turnover markers in the vertebrae of ovaryintact and ovariectomized adult rats. Biochem Cell Biol 84:728–736 Hennig B, Meerarani P, Toborek M, McClain CJ (1999) Antioxidant-like properties of zinc in activated endothelial cells. J Am Coll Nutr 18:152–158 Hoshino T, Yamada K, Masuoka K, Tsuboi I, Itoh K, Nonaka K, Oizumi K (1994) Elevated adenosine deaminase activity in the serum of patients with diabetes mellitus. Diabetes Res Clin Pract 25:97–102 Ikeda Y, Suehiro T, Inoue T, Nakauchi Y, Morita T, Arii K, Ito H, Kumon Y, Hashimoto K (1998) Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus. Metabolism 47:598–602 Ingram GI, Hills M (1976) Reference method for the one-stage prothrombin-time test on human blood. Thromb Haemost 36:237–238 Jansen J, Karges W, Rink L (2009) Zinc and diabetes-clinical links and molecular mechanisms. J Nutr Biochem 20:399–417 Kanth VR, Reddy PUM, Raju TN (2008) Attenuation of streptozotocin-induced oxidative stress in hepatic and intestinal tissues of Wistar rat by methanolic-garlic extract. Acta Diabetol 45:243–251 Karatug A, Sacan O, Coskun ZM, Bolkent S, Yanardag R, Turk N, Bolkent S (2012) Regulation of gene expression and biochemical changes in small intestine of newborn diabetic rats by exogenous ghrelin. Peptides 33:101–108 Karatug A, Kaptan A, Bolkent S, Mutlu O, Yanardag R (2013) Alterations in kidney tissue following zinc supplementation to STZ-induced diabetic rats. J Trace Elem Med Biol 27:52–57 Karker H (1964) Method for estimation of serum adenosine deaminase. Scand J Clin Lab Invest 16:570–574
Koksel O, Ozdulger A, Ercil M, Tamer L, Ercan B, Atik U, Cinel L, Cinel L, Kanik A (2004) Effects of N-acetylcysteine on oxidant-antioxidant balance in oleic acid-induced lung injury. Exp Lung Res 30:431–436 Konukoglu D, Serin O, Akcay T, Hatemi H (1999) Relationship between diabetic angiopathic complications and serum total and lipid associated sialic acid concentrations. Med Sci Res 27:53–55 Kumar PA, Haseeb A, Suryanarayana P, Ehtesham NZ, Reddy GB (2005) Elevated expression of aA- and aB-crystallins in streptozotocin-induced diabetic rat. Arch Biochem Biophys 444:77–83 Ledwozyw A, Michalak J, Stepien´ A, Kadziołka A (1986) The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin Chim Acta 155:275–283 Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stantman ER (1990) Determination of carbonyl content in oxidatively modified proteins. In: Packer L, Glazer AN (eds) Methods in enzymology, oxygen radicals in biological systems, vol 186. Academic Press, California, pp 464–478 Lorentz K, Weiss T, Kraas E (1986) Sialic acid in human serum and cerebrospinal fluid. Comparison of methods and reference values. J Clin Chem Clin Biochem 24:189–198 Lowry OH, Rosebrough HJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275 Mackness B, Durrington PN, Abuashia B, Boulton AJM, Mackness MI (2000) Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy. Clin Sci 98:355–363 Maritim AC, Sanders RA, Watkins JB III (2003) Diabetes oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17:24–38 Marjani A, Moradi A, Saeedi M (2005) Plasma lipid peroxidation, zinc and erythrocyte Cu—Zn superoxide dismutase enzyme activity in patients with type 2 diabetes mellitus in Gorgan city (south east of the Caspian Sea). J Med Sci 7:585–590 Marvisi Mi Bartolini L, del Borello P, Brianti M, Marani G, Guariglia A, Cuomo A (2001) Pulmonary function in noninsulin-dependent diabetes mellitus. Respiration 68:268–272 Matsumoto S, Koshiishi I, Inoguchi T, Nawata H, Utsumi H (2003) Confirmation of superoxide generation via xanthine oxidase in streptozotocin-induced diabetic mice. Free Radic Res 37:767–772 Muruganathan U, Srinivasan S, Indumathi D (2013) Antihyperglycemic effect of carvone: effect on the levels of glycoprotein components in streptozotocin-induced diabetic rats. J Acute Disease 2:310–315 Mylorie AA, Colins H, Umbles C, Kyle J (1986) Erythrocyte superoxide dismutase activity and other parameters of copper status in rats ingesting lead acetate. Toxicol Appl Pharmacol 82:512–520 Oberley LW (1988) Free radicals and diabetes. Free Radic Biol Med 5:113–124 Ozsoy N, Can A, Mutlu O, Akev N, Yanardag R (2012) Oral zinc supplementation protects rat kidney tissue from oxidative stress in diabetic rats. Kafkas Univ Vet Fak 18:545–550
123
Biometals Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169 Pari L, Ashokkumar N (2006) Glycoprotein changes in noninsulin dependent diabetic rats: effect of N-benzoyl-Dphenylalanine and metformin. Therapie 61:125–131 Parker KM, England JD, Da Costa J, Hess RL, Goldstein DE (1981) Improved colorimetric assay for glycosylated haemoglobin. Clin Chem 27:669–672 Parui R, Gambhir KK, Cruz I, Hosten AO (1992) Erythrocyte carbonic anhydrase: a major intracellular enzyme to regulate cellular sodium metabolism in chronic renal failure patients with diabetes and hypertension. Biochem Int 26:809–820 Patti ME, Virkama¨ki A, Landaker EJ, Kahn CR, Yki-Ja¨rvinen H (1999) Action of the hexosamine pathway by glucosamine in vivo induces insulin of early postreceptor insulin signaling events in skeletal muscle. Diabetes 48:1562–1571 Pinter E, Peyman JA, Snow K, Jamieson JD, Warshaw JB (1991) Effects of maternal diabetes on fetal rat lung ion transport. Contribution of alveolar and bronchiolar epithelial cells to Na?, K?-ATPase expression. J Clin Invest 87:821–830 Prasad AS (1993) Clinical spectrum of human zinc deficiency. In: Prasad AS (ed) Biochemistry of zinc. Plenum Press, New York, pp 219–258 Prasad AS (2008) Zinc in human health: effect of zinc on immune cells. Mol Med 14:353–357 Prasad AS (2014) Zinc is an antioxidant and anti-inflammatory agent: its role in human health. Front Nutr 1:14 Prasad AS, Bao B, Beck FWJ, Kucuk O, Sarkar FH (2004) Antioxidant effect of zinc in humans. Free Radic Biol Med 37:1182–1190 Punithavathi VR, Prince PSM, Kumar MR, Selvakumari CJ (2011) Protective effects of gallic acid on hepatic lipid peroxide metabolism, glycoprotein components and lipid in streptozotocin-induced type II diabetic wistar rats. J Biochem Mol Toxicol 25:68–76 Rauch U, Nemerson Y (2000) Circulating tissue factor and thrombosis. Curr Opin Hematol 7:273–277 Reedy GK, Enwemeka CS (1996) A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 29:225–229 Ridderstap AS, Bonting SL (1969) Na?-K?-activated ATPase and exocrine pancreatic secretion in vitro. Am J Physiol 217:1721–1727 Rodrigo R, Trujillo S, Bosco C, Orellana M, Thielemann L, Araya J (2002) Changes in (Na ? K)-adenosine triphosphatase activity and ultrastructure of lung and kidney associated with oxidative stress induced by acute ethanol intoxication. Chest 121:589–596 Rutkiewicz J, Go´rski J (1990) On the role of insulin in regulation of adenosine deaminase activity in rat tissues. FEBS Lett 271:79–80 Shah GS, Morofuji Y, Banks WA, Price TO (2013) High glucose-induced mitochondrial respiration and reactive oxygen species in mouse cerebral pericytes is reversed by
123
pharmacological inhibition of mitochondrial carbonic anhydrases: implications for cerebral microvascular disease in diabetes. Biochem Biophys Res Commun 440:354–358 Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106:171–176 Sulaiman GM, Al-Amiery AA, Mohammed AA, Al-Temimi AA (2012) The effect of cherry sticks extract on the levels of glycoproteins in alloxan-induced experimental diabetic mice. Ann Clin Lab Sci 42:34–41 Sundaram R, Naresh R, Shanthi P, Sachdanandam P (2012) Antihyperglycemic effect of iridoid glucoside, isolated from the leaves of Vitex negundo in streptozotocin-induced diabetic rats with special reference to glycoprotein components. Phytomedicine 19:211–216 Tran B, Oliver S, Rosa J, Galassetti P (2012) Aspects of inflammation and oxidative stress in pediatric obesity and type 1 diabetes: An overview of ten years of studies. Exp Diabetes Res. Article ID 683680 Tunali S, Yanardag R (2013) Protective effect of vanadyl sulfate on skin injury in streptozotocin-induced diabetic rats. Hum Exp Toxicol 32:1206–1212 Vallee BL, Falchuk KH (1993) The biochemical basis of zinc physiology. Physiol Rev 73:79–118 Verpoorte JA, Mehta S, Edsall JT (1967) Esterase activities of human carbonic anhydrases B and C. J Biol Chem 242:4221–4229 Wei H, Frenkel K (1991) In vivo formation of oxidized DNA bases in tumor promoter-treated mouse skin. Cancer Res 51:4443–4449 Wendel A (1981) Glutathione peroxidase. Methods Enzymol 77:325–333 Wiese TJ, Dunlap JA, Yorek MA (1997) Effect of L-fucose and D-glucose concentration on L-fucoprotein metabolism in human Hep G2 cells and changes in fucoyltransferase and a-L-fucosidase activity in liver of diabetic rats. Biochim Biophys Acta 1335:61–72 Wijesekara N, Chimienti F, Wheeler MB (2009) Zinc, a regulator of islet function and glucose homeostasis. Diabetes Obes Metab 11:202–214 Winzler RJ (1955) Determination of serum glycoproteins. In: Glick DP (ed) Methods of biochemical analysis. Interscience Publisher Inc, New York, pp 279–311 Witko-Sarsat V, Friedlander M, Capeille´re-Blandin C, NguyenKhoa T, Nguyen AT, Zingraff J, Jungers P, DescampsLatscha B (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304–1313 Wroblewski F (1957) Clinical significance of serum enzyme alterations associated with myocardial infarction. Am Heart J 54:219–224 Yanardag R, Tunali S (2006) Vanadyl sulfate administration protects the streptozotocin-induced oxidative damage to brain tissue in rats. Mol Cell Biochem 286:153–159
Zinc supplementation ameliorates glycoprotein components and oxidative stress changes in the lung of streptozotocin diabetic rats Ozlem Sacan . Ismet Burcu Turkyilmaz . Bertan Boran Bayrak . Ozgur Mutlu . Nuriye Akev . Refiye Yanardag
Received: 3 September 2015 / Accepted: 15 January 2016 Springer Science+Business Media New York 2016
Abstract Zinc (Zn) is a component of numerous enzymes that function in a wide range of biological process, including growth, development, immunity and intermediary metabolism. Zn may play a role in chronic states such as cardiovascular disease and diabetes mellitus. Zn acts as cofactor and for many enzymes and proteins and has antioxidant, antiinflammatory and antiapoptotic effects. Taking into consideration that lung is a possible target organ for diabetic complications, the aim of this study was to investigate the protective role of zinc on the glycoprotein content and antioxidant enzyme activities of streptozotocin (STZ) induced diabetic rat tissues. Female Swiss albino rats were divided into four groups. Group I, control; Group II, control ? zinc sulfate; Group III, STZ-diabetic; Group IV, diabetic ? zinc sulfate. Diabetes was induced by intraperitoneal injection of STZ (65 mg/kg body weight). Zinc sulfate was given daily by gavage at a dose of 100 mg/kg body weight every day for 60 days to groups II and IV. At the last day of the experiment, rats were sacrificed, lung tissues were
taken. Also, glycoprotein components, tissue factor (TF) activity, protein carbonyl (PC), advanced oxidative protein products (AOPP), hydroxyproline, and enzyme activities in lung tissues were determined. Glycoprotein components, TF activity, lipid peroxidation, non enzymatic glycation, PC, AOPP, hydroxyl proline, lactate dehydrogenase, catalase, superoxide dismutase, myeloperoxidase, xanthine oxidase, adenosine deaminase and prolidase significantly increased in lung tissues of diabetic rats. Also, glutathione levels, paraoxonase, arylesterase, carbonic anhydrase, and Na?/K?- ATPase activities were decreased. Administration of zinc significantly reversed these effects. Thus, the study indicates that zinc possesses a significantly beneficial effect on the glycoprotein components and oxidant/antioxidant enzyme activities. Keywords Zinc Diabetes mellitus Lung Glycoprotein Oxidative stress
Introduction O. Sacan I. B. Turkyilmaz B. B. Bayrak O. Mutlu R. Yanardag (&) Department of Chemistry, Faculty of Engineering, Istanbul University, 34320 Avcilar/Istanbul, Turkey e-mail: [email protected] N. Akev Department of Biochemistry, Faculty of Pharmacy, Istanbul University, 34116 Istanbul, Turkey
Diabetes mellitus (DM) is a clinical syndrome associated with oxidative stress and is a major cause of serious micro and macrovascular diseases that affect nearly every system in the body, including respiratory system. Lung is a target organ in diabetic patients (Marvisi et al. 2001). Diabetic patients are at increased risk of several pulmonary complications such as
123
Biometals
asthma, inflammatory infectious diseases and chronic obstructive pulmonary disease (American Diabetes Association 2010). Glycoproteins are rich in extracellular matrix, and they contribute as a major source to matrix structure (Wiese et al. 1997). These groups of macromolecules carry out numerous biological functions including vitamins and lipid transport, hemoglobin binding, play role in signal transduction as hormone receptors, and immunological specifity and blood coagulation. Raised levels of glycoproteins in diabetics may also be a predictor of angiopathic complications (Konukoglu et al. 1999). Hyperglycemia mediated oxidative stress and inflammation plays a major role in the development of diabetic complications and tissue injury. Reactive oxygen species (ROS) have also been proposed to be involved in many serious diseases. In diabetes, oxidative stress that is caused by excess ROS is symmetrically increased, because high glucose levels generate ROS in a variety of cell types (Maritim et al. 2003). It has been reported that diabetes induces alterations in the activities of antioxidant enzymes in various tissues (Oberley 1988). Several trace elements are involved in glucose metabolism. Zn is an essential mineral that is required for various cellular functions. Zn deficiency has been shown to play a role of multiple diseases, such as malabsorption syndrome, sickle cell disease, chronic liver disease, hypogonadism, dermatitis, teratogeny and diabetes (Prasad 1993). In the case of diabetes, zinc is considered important mainly because it plays a major role in the stabilization of insulin hexamers and the pancreatic storage of the hormone (Wijesekara et al. 2009). Zn was reported to improve glycemia, and to restore zinc status in patients (Marjani et al. 2005) or animals (Ozsoy et al. 2012) with type-2 diabetes, by counteracting the deleterious effects of oxidative stress and thus helps to prevent complications associated with the disease. Zn may act by different protection mechanisms, as cofactor for many enzymes and proteins and may play a critical role as a potent anti-oxidant and anti-inflammatory agent (Hennig et al. 1999; Prasad et al. 2004; Prasad 2008; Jansen et al. 2009). As an antioxidant, Zn act by two different mechanisms: In the first mechanism, Zn protects sulfhydryl groups against oxidation. In the second mechanism, it inhibits production of ROS. The aim of this study was to investigate the protective role of Zn in streptozotocin—(STZ)
123
induced diabetic lung tissues and try to elucidate its mechanism of action through the changes in the content of glycoprotein components and the activities of several enzymes.
Biochemical estimations Animals Female, 6–6.5 months old, clinically healthy Swiss albino rats were used. The rats were randomly divided into four groups. Experimental design Group I: control (untreated) animals; Group II: control animals given zinc sulfate: Group III: diabetic animals; Diabetes was induced by intraperitoneal injection of streptozotocin (STZ) in a single dose of 65 mg/kg. STZ was dissolved in a freshly prepared 0.01 M pH 4.5 citrate buffer. Blood glucose levels over 200 mg/dL were considered as diabetic and taken into the diabetic group (Bolkent et al. 2009). Group IV: diabetic animals given zinc sulfate. Zinc sulfate was given to groups II and IV by gavage at a dose of 100 mg/kg body weight, every day, for 60 days. The ZnSO4 solution was given to IV groups after the induction of diabetes. The animals were fasted overnight prior to experiment, but they were allowed free access to water. At the last day of the experiment, lung tissue was taken from animals. In this study, biochemical investigations were undertaken in lung tissue from all groups. For biochemical analyses, the tissue samples were washed with saline and kept frozen until the day of the experiment. These tissue samples were homogenized in cold 0.9 % NaCl with a glass homogenizer to make up 10 % (w/v) homogenate. The homogenates were centrifuged. The supernatant fraction was removed for the determination of glycoprotein components, glutathione (GSH), lipid peroxidation (LPO), nonenzymatic glycations (NEG), advanced oxidation protein products (AOPP), protein carbonyl (PC), hydroxyproline (OH-proline) and protein levels and enzyme activities. Hexose and hexosamine levels were determined according to Winzler’s method (1955). Fucose levels in lung homogenates were estimated by Dische and Shettles’s method (1948). Lung tissue sialic acid was assessed by the Lorenz et al. method (1986). Tissue
Biometals
factor (TF) activity of lung tissue was evaluated according to Quick’s one-stage method using normal plasma (Ingram and Hills 1976). GSH and LPO levels were evaluated by the method described by Beutler (1975) and Ledwozyw et al. (1986) respectively. Parker et al. (1981) method was used to analyse the lung NEG. PC and AOPP levels were measured by the method of Levine et al. (1990) and Witko-Sarsat et al. (1996). Lung OH-proline levels were assayed by the method of Reedy and Enwemeka (1996). Catalase (CAT) activity was assayed in lung tissues by the method of Aebi (1984). Lung superoxide dismutase (SOD) activity was assayed by the method described by Mylorie et al. (1986). Glutathione peroxidase (GPx) activity was determined by the method described by Paglia and Valentine (1967) and modified by Wendel (1981). Myeloperoxidase (MPO) activity was determined by the method described Wei and Frenkel (1991). Lactate dehydrogenase (LDH) activity was determined by the method of Wroblewski (1957). Furlong et al. (1988) method was used to analyse the lung tissue paraoxanase activity. Arylesterase (ARE) activity was done by the method of Gan et al. (1991). Carbonic anhydrase (CA) activity was assayed by the method described by Verpoorte et al. (1967). Sodium potassium ATPase (Na?/K?-ATPase) activity was determined by the method of Ridderstap and Bonting (1969). Lung prolidase activity was determined by the method described Chinard (1952). Karker (1964) and Corte and Stirpe (1968) methods were used to analyse
the lung adenosine deaminase (ADA) and xanthine oxidase (XO) activities. The protein content was estimated by the method of Lowry using bovine serum albumin as standard (Lowry et al. 1951). Statistical analysis Biochemical results were analysed by two-way ANOVA and Mann–Whitney U test by using GraphPad Prism version 4.0 computer package. Results were reported as mean ± SD. P values less than 0.05 were considered to be significant.
Results Table 1 shows the changes in the level of tissue glycoprotein components and TF activity of control and experimental rats. The levels of glycoproteins containing hexose, hexosamine, fucose and sialic acid (P \ 0.005, P \ 0.0001 and P \ 0.005, respectively) were significantly increased whereas TF activity was significantly decreased (P \ 0.05) in the diabetic group. Administration of Zn significantly reversed these changes in glycoprotein components (P \ 0.001, P \ 0.0001, P \ 0.005 and P \ 0.0001 respectively) and TF activity (P \ 0.005) in the lung of diabetic rats (Table 1). GSH, LPO, NEG, PC, AOPP and OH-proline levels are presented in Table 2. A significant decrease was observed in lung tissue GSH levels in STZ-diabetic
Table 1 Lung tissue hexose, hexosamine, fucose, sialic acid and tissue factor (TF) levels of all groups Group
Hexose (mg glucose/mg protein)*
Hexosamine (lg glucosamine/mg protein)*
Fucose (lg fucose/mg protein)*
Sialic Acid (lmole sialic acid/g protein)*
TF (Sec)*
Control
3.45 ± 0.30
7.65 ± 0.56
7.62 ± 0.94
147.18 ± 5.82
229.67 ± 22.81
Control ? Zn
3.11 ± 0.11
5.33 ± 0.71
4.45 ± 0.54
164.86 ± 7.07
270.25 ± 16.82
Diabetic
9.41 ± 1.56a
41.59 ± 2.53c
14.16 ± 2.15a
276.14 ± 14.00a
186.80 ± 8.79f
Diabetic ? Zn
4.75 ± 0.55b
15.55 ± 1.78d
2.39 ± 0.14e
162.06 ± 8.22d
233.50 ± 4.95e
* Mean ± SD a
P \ 0.005 versus control group
b
P \ 0.001 versus diabetic group
c
P \ 0.0001 versus control group
d
P \ 0.0001 versus diabetic group
e
P \ 0.005 versus diabetic group
f
P \ 0.05 versus control group
123
Biometals Table 2 Lung GSH, LPO, NEG, PC, AOPP and OH-proline levels of all groups Group
Control Control ? Zn Diabetic Diabetic ? Zn
GSH (nmol GSH/mg protein) *
LPO (nmol MDA/mg protein)*
NEG (nmol fructose/mg protein)*
PC (nmol carbonyl/mg protein)*
AOPP (pmol/mg protein)*
OH-Proline (lg/g tissue)*
9.92 ± 1.25
0.67 ± 0.09
6.39 ± 1.03
14.18 ± 2.25
7.79 ± 1.03
12.27 ± 1.32a
0.86 ± 0.11a
10.86 ± 0.88e
23.18 ± 3.85a
4.88 ± 0.76
5.03 ± 1.65b
1.30 ± 0.41b
24.27 ± 5.42f
65.25 ± 6.21b
10.96 ± 1.30a
81.45 ± 3.24a
13.09 ± 2.61c
0.90 ± 0.10d
17.01 ± 2.02
21.70 ± 2.85c
6.40 ± 0.56d
73.90 ± 1.95
g
68.43 ± 8.50 h
71.37 ± 7.67 g
* Mean ± SD a
P \ 0.05 versus control group
b
P \ 0.0001 versus control group
c
P \ 0.0001 versus diabetic group
d
P \ 0.001 versus diabetic group
e
P \ 0.0001 versus control group
f
P \ 0.001 versus control group
g
P \ 0.05 versus diabetic group
h
P \ 0.005 versus control group
rats (P \ 0.0001). LPO, NEG, PC, AOPP and OHproline levels were significantly increased in STZdiabetic rats (P \ 0.0001, P \ 0.001, P \ 0.0001 and P \ 0.05, respectively). Administration of Zn significantly decreased the levels of these parameters (P \ 0.0001, P \ 0.001, P \ 0.05, P \ 0.0001, P \ 0.001 and P \ 0.05, respectively) (Table 2). The LDH, CAT, SOD, GPx and MPO activities in the lung tissue are presented in Table 3. Lung LDH, CAT, SOD, GPx and MPO activities were significantly increased in STZ-diabetic rats (P \ 0.0001, P \ 0.001 and P \ 0.0001, respectively). Zn treatment caused a significant decrease in the activities of these enzymes (P \ 0.0001, P \ 0.0001, P \ 0.0001, P \ 0.05 and P \ 0.0001 respectively) (Table 3). The paraoxonase, ARE, XO and ADA activities in the lung tissue are presented in Table 4. Lung paraoxonase and ARE activities were significantly decreased (P \ 0.0001 and P \ 0.005 respectively), while lung XO and ADA activities were significantly increased in diabetic rats (P \ 0.01 and P \ 0.05 respectively). Treatment with Zn reversed these changes (P \ 0.0001, P \ 0.05 and P \ 0.005, respectively) (Table 4). The CA, Na?/K?- ATPase and prolidase activities in the lung tissue are shown in Table 5. Lung CA and Na?/K?-ATPase activities were significantly decreased in diabetic group compared to control group (P \ 0.0001 respectively). A significant reduction in
123
CA and Na?/K?-ATPase activities was also seen in the control group given Zn (P \ 0.0001, P \ 0.05 respectively). Administration of Zn significantly increased CA and Na?/K?-ATPase activities in diabetic group (P \ 0.0001, respectively). Prolidase activity in lung tissue was significantly increased in diabetic group compared to control group (P \ 0.0001). However, treatment with Zn significantly decreased prolidase activity in diabetic group (P \ 0.0001) (Table 5).
Discussion Diabetes mellitus is a serious metabolic disorder with micro and macrovascular complications that results in significant morbidity and mortality. Metal ions are known to play an essential role in living systems both in growth and in metabolism. DM is associated with hyperglycemia and with accelerated non-enzymatic glycation, increased oxidative stress and free radical production. Hyperglycemia causes local biochemical in changes in lungs resulting in reduced antioxidant defense. Abnormalities of glycoprotein metabolism are commonly observed both naturally and experimental diabetes (Kumar et al. 2005; Pari and Ashokkumar 2006). Insulin deficiency and high levels of serum glucose may result in an increased synthesis of
Biometals Table 3 Lung LDH, CAT, SOD, GPx and MPO activities of all groups Group
LDH (U/mg protein) *
CAT (U/mg protein)*
SOD (U/g protein)*
GPX (U/g protein)*
MPO (mU/g tissue)*
Control
390.44 ± 26.88
23.71 ± 6.92
15.39 ± 1.87
26.13 ± 0.22
Control ? Zn
145.75 ± 13.49a
49.23 ± 1.49c
14.01 ± 0.23
10.00 ± 2.40a
2.62 ± 0.28f
a
14.84 ± 1.39a 5.65 ± 0.95b
Diabetic Diabetic ? Zn
579.12 ± 34.83 156.89 ± 9.76b
a
d
105.22 ± 13.27 13.30 ± 0.78b
a
26.77 ± 2.20 14.66 ± 0.57b
3.39 ± 0.70
6.86 ± 0.78 9.91 ± 0.39e
* Mean ± SD a
P \ 0.0001 versus control group
b
P \ 0.0001 versus diabetic group
c
P \ 0.005 versus control group
d
P \ 0.001 versus control group
e
P \ 0.05 versus diabetic group
f
P \ 0.05 versus control group
Table 4 Lung paraoxonase, ARE, XO and ADA activities of all groups Group
Paraoxonase (U/g protein)*
ARE (kU/g protein)*
XO (U/mg protein)*
ADA (U/g protein)*
Control
16.41 ± 3.34
5.38 ± 0.63
0.17 ± 0.03
86.78 ± 4.94
Control ? Zn
13.42 ± 0.43a
5.42 ± 0.58
0.12 ± 0.02a
88.12 ± 10.22
6.74 ± 0.82b
3.67 ± 0.46d
0.25 ± 0.02f
97.14 ± 4.03a
18.77 ± 2.49c
5.82 ± 0.25e
0.15 ± 0.04
Diabetic Diabetic ? Zn
g
61.27 ± 8.85
g
* Mean ± SD a
P \ 0.05 versus control group
b
P \ 0.0001 versus control group
c
P \ 0.0001 versus diabetic group
d
P \ 0.005 versus control group
e
P \ 0.05 versus diabetic group
f
P \ 0.01 versus control group
g
P \ 0.005 versus diabetic group
Table 5 Lung CA, Na?/K?- ATPase, prolidase activities of all groups Group
CA (U/mg protein)*
Na?/K?- ATPase (nmol P/mg protein/h)*
Control
49.21 ± 3.15
11.65 ± 1.05
Control ? Zn Diabetic Diabetic ? Zn
a
27.00 ± 1.06
a
15.08 ± 1.49
b
21.13 ± 1.31
Prolidase (U/g protein)* 66.80 ± 4.11
c
32.07 ± 1.79a
a
102.63 ± 5.08a
b
41.03 ± 4.24b
6.09 ± 0.36 1.74 ± 0.02 3.24 ± 0.45
* Mean ± SD a
P \ 0.0001 versus control group
b
P \ 0.0001 versus diabetic group
c
P \ 0.05 versus control group
123
Biometals
glycoprotein components such as hexose, hexosamine, fucose and sialic acid (Patti et al. 1999). In this study, we have observed increased levels of hexose, hexosamine, fucose and sialic acid in the lung tissue of STZ diabetic rats. Glycoproteins contribute as a major source to the structure of the matrix, they have multiple and complex functions as enzymes, hormones, blood group substances and as constituents of extracellular membranes (Muruganathan et al. 2013). In this study, Zn treatment in diabetic rats reversed the alterations in the glycoprotein components towards near normal levels. This shows that Zn can normalize the glycoprotein metabolism which is altered in diabetes. Decreased hyperglycemic state with treatment Zn in diabetic rats might be responsible for the beneficial changes in glycoprotein in lung. Our results were in agreement with the results of Sulaiman et al. (2012) and Muruganathan et al. (2013). TF is considered to be a major regulator of normal haemostasis and thrombosis (Rauch and Nemerson 2000). TF is involved in the pathophysiology of systemic inflammatory disorders, coagulopathies and tumor angiogenesis. TF activity is also suggested to be a marker associated with DM (Emekli-Alturfan et al. 2007). Various tissues and body fluids such as lung, brain, testis, heart, kidney and aorta have been known to have TF activity (Emekli-Alturfan et al. 2007). The lung tissue had the highest TF activity. In the present study, TF activity was increased in diabetic lung tissue. Treatment with Zn significantly decreased the TF activity in diabetic rats. This decrease may be due to the antiinflammatory effect of Zn. This restoration in TF activity in diabetic group given Zn, might protect lung tissue from the risk of thrombosis. Accordingly, Emekli-Alturfan et al. (2007) have shown that TF activity is increased in the lung of diabetic rats. Elevation of free radical levels can in turn lead to increased lipid peroxidation and decreased levels of GSH. In the present study, LPO levels (expressed as MDA) in DM group were found to be significantly higher than in the control group in lung tissue. Zn significantly decreased MDA production. Additionally Zn significantly increased GSH levels. LPO increase leads to the release of lysosomal and mitochondrial matrix proteolytic enzymes into the cytoplasm. Similar results were reported in diabetic animals (Tunali and Yanardag 2013; Gezginci-Oktayoglu et al. 2014). Several studies reported the effect
123
of Zn in reducing diabetes and its antioxidant property (Ozsoy et al. 2012; Karatug et al. 2013). Thus we can postulate like Vallee and Falchuk (1993) that Zn may play a role in protecting the cell from oxidative stress by decreasing LPO. NEG may increase due to increased oxidative stress. In this study, NEG levels were found to increase in diabetic rats. In our previous studies, we have demonstrated that NEG level were increased in diabetic rats (Yanardag and Tunali 2006). It has been reported that various plant extracts, vitamins and some transition metals prevent the increase of tissue NEG levels in diabetic rats (Gezginci-Oktayoglu et al. 2009). In this study, NEG levels which were increased in diabetic rat lung tissue, were decreased with the administration of Zn. NEG results support the fact that administration of Zn is able to reduce the oxidative stress in diabetic animals. PC levels are routinely used as a biomarker for protein damage caused by oxidized amino acid residues in stress conditions. In our study PC levels were significantly higher in diabetic rats. Several studies have reported increased levels of PC in diabetic animals (Karatug et al. 2012). Our data are in agreement with other research and confirm the presence of increased oxidative damage in DM (Gezginci-Oktayoglu et al. 2011, 2014). In this study, Zn treatment to diabetic rats reversed the increase in PC levels by the regression of oxidative stress through their antioxidant and hypoglycemic properties. AOPP are another marker that indicates oxidative stress-based protein damage (Kanth et al. 2008). Some authors have reported the elevation of AOPP in diabetic patients (Baskol et al. 2008; Brzovic´-Sˇaric´ et al. 2015). In our study, AOPP levels were increased in diabetic lung tissues. Also, Zn treatment to diabetic rats reversed this increase. This result indicated that Zn may be effective in preventing oxidative protein damage. Hydroxyproline content is commonly used as an indicator of the amount of collagen in wound tissue. In the present study, the hydroxyproline levels were significantly increased in diabetic rats indicating the negative destructive of diabetes on lung collagen. This result is consistent with that of the previous study (Gopalakrishnan et al. 2006). Zn administration reverse this increase showing the restoration of collagen damage. LDH is a terminal glycolytic enzyme that plays an indispensable role in the interconversion pyruvate to
Biometals
lactate to yield energy under anaerobic conditions. LDH activity is altered by insulin, glucose and NADH. Increased LDH activity in diabetic rats and patients is associated with impaired glucose stimulated insulin secretion (Shulman 2000). Similarly in our study, there was an increase in activity of LDH in the lung of diabetic animals. Administration of Zn restored LDH activity to normal level. Endogenous antioxidant enzymes CAT and SOD are responsible for the detoxification of deleterious oxygen radicals and play an important role in protecting cell form oxidative damage. In the present study, we have observed an increase in the activities of CAT and SOD in the lung tissue of diabetic rats. The increase in CAT activity in lung tissue may indicate a high degree of oxidative stress resulting in the increased endogenous H2O2. In the present study, the increased SOD activity may be another sign for the oxidative stress in the lung tissue. Zn might be a scavenger for the free radicals. Therefore, it might prevent the elevation of the activities of CAT and SOD in diabetic rat lung. Plasma and tissue MPO activity is valuable marker of chronic inflammation which is common in type 1 diabetes patients (Tran et al. 2012). Accordingly, in this study, MPO activity increased in the lung tissue of diabetic rats. Treatment with Zn significantly reduced the MPO activities of diabetic rats. We suggest that Zn decreases MPO-induced ROS generation and consequently may reduce lung damage in diabetic rats. PON1 is a calcium dependent enzyme. PON1 has three known enzymatic molecules including paraoxonase, arylesterase and dyazoxonase. PON1 activity has been linked to a variety of human conditions and diseases such as inflammation, myocardial infarction, stroke, Alzheimer’s and diabetes (Camps et al. 2009). Decreased PON1 activity may be in response to inflammation in patients with diabetes and cancer (Devarajan et al. 2014). Various researchers reported that PON1 activity decreased in patients with type 1 and 2 diabetes (Ikeda et al. 1998; Mackness et al. 2000). Accordingly, in the present study, PON1 and arylesterase activities were reduced in the STZ diabetic rats. Decreased PON1 and arylesterase activities in diabetic rats might be related to hyperglycemia and oxidative stress. Lung paraoxonase and arylesterase activities were increased in diabetes ?Zn group and might be related to the direct stimulating effect of Zn on PON 1 and arylesterase or to its antioxidant properties.
In the current study, XO activity was increased in DM group when compared with the control group. Zinc also significantly decreased XO activity. XO can act as an important biological source of ROS. According to a previous study, tissue XO activity is increased in experimental diabetes and this contributes to superoxide production (Matsumoto et al. 2003). Increased XO activities in diabetic rats may lead to enhanced oxidative stress in the lung, leading to secondary organ damage associated with diabetes. Treatment with Zn significantly protected the lung against XO-derived ROS formation via pathways of XO inhibition in hyperglycemic rats. ADA is suggested to be an important enzyme for modulating the bioactivity of insulin (Hoshino et al. 1994). Rutkiewicz and Go´rski (1990) has shown an increase in ADA activity in tissues of STZ induced diabetic rats. Similarly, in another study conducted by us, ADA activity increased in diabetic liver tissue and chard, inhibited ADA activity and reduced glucose levels in hyperglycemic rats (Gezginci-Oktayoglu et al. 2014). The results of the present study demonstrated that ADA activity was increased in diabetic lung tissue. Zn treatment to diabetic rats reversed this increase. The activity of CA in various diseases has been studied and different changes in CA activity have been associated with an altered metabolism in DM. Several studies showed that CA activity was directly proportional with increasing blood glucose concentration (Shah et al. 2013; Biswas and Kumar 2012). Parui et al. (1992) showed that erythrocyte receptor-bound insulin increased CA activity and, Abel et al. (1997) reported lower CA activity in type I diabetic patients. The fact that Zn is the cofactor of CA could be the reason of the decrease of activity in the control group given Zn, due to feed-back mechanism. Nevertheless the significant decrease in CA activity seen in the diabetic group was restored by administration on zinc to the control ? zinc sulphate group’s levels. Na?/K?- ATPase, are enzymes located in the cell membrane responsible for the active transport of various ions, and are highly sensitive to free radical reactions. These enzymes are very susceptible to structural changes due to lipid peroxidation (Rodrigo et al. 2002). For this reason, Na?/K?- ATPase activity can be used as an index for the degree of LPO (Koksel et al. 2004). A decrease of Na?/K?- ATPase can indicate membrane injury (Ariciog˘lu et al. 1994). Decreased lung Na?/K?- ATPase activity may result
123
Biometals
in the loss of physiologic function of lung tissue. In our study, Na?/K?- ATPase decreased in STZ diabetic rats. Similarly, Pinter et al. (1991) indicated a decrease in lung Na?/K?- ATPase activity in STZ-treated rats. Treatment with zinc significantly increased the Na?/ K?- ATPase activity. Zn might have prevented the inhibition of Na?/K?- ATPase by means of detoxification of reactive oxygen radicals. In diabetic patients and animals, high blood glucose levels may delay proliferation of cells and decrease collagen production. Furthermore, prolidase may increase breakdown of collagen (Araki et al. 2010; Bradley et al. 2000). The changing in prolidase enzyme activity is associated with this recycling of proline. The degree of oxidative stress is related to the inhibition of collagen production. In the present study, we have investigated the activity of prolidase activity and hydroxyproline levels in diabetic rats with the idea that might be related to collagen breakdown in the pathogenesis of DM. In our study, we have found that lung prolidase activity was significantly higher in diabetic rats than in controls. The increase in prolidase activity is considered to be correlated with the increased intensity of collagen breakdown. In addition, we found that lung hydroxyproline levels were significantly higher in diabetic groups. Treatment with zinc reduced the prolidase activity and hydroxyproline levels to similar levels of controls. These findings can support a relationship between the pathogenesis of diabetes mellitus and collagen turnover. Trace element metabolism has been reported to possess specific roles in the pathogenesis and progress of diabetes mellitus (Badran et al. 2016). Early reports indicate that zinc has antioxidant, antidiabetic and anti-inflammatory effects (Prasad 2008, 2014). The breaking down of glycoprotein levels and enzyme activities in STZ-diabetic rats were shown in some studies (Punithavathi et al. 2011; Sundaram et al. 2012; Muruganathan et al. 2013). In our study, it was observed that administration of Zn repaired these activities in STZ-diabetic rats. As a result, we can postulate that zinc has a protective effect in diabetic lung tissue probably through activation of enzymes related to oxidative stress, anti-inflammatory mechanism and reduction of collagen injury. Acknowledgments This work was supported by Istanbul University Scientific Research Projects. Project Number: UDP37282.
123
References Abel P, Wussow S, Blu¨cher H, Gros G, Retting R, Honig A (1997) Erythrocyte carbonic anhydrase activity in smokers and diabetic patients. Exp Clin Endocrinol Diabetes 105:17–19 Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126 American Diabetes Association (2010) Standards of medical care in diabetes-2010. Diabetes Care 33:S11–S61 Araki S, Haneda M, Koya D, Isshiki K, Kume S, Sugimoto T, Kawai H, Nishio Y, Kashiwagi A, Uzu T, Maegawa H (2010) Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria. Diabetes Care 33:1805–1810 Ariciog˘lu A, Aydin S, Turkozkan N, Durmus O (1994) The effect of allopurinol on Na ? K ? ATPase related lipid peroxidation in ischemic and reperfused rabbit kidney. Gen Pharmacol 25:341–344 Badran M, Morsy R, Soliman H, Elnimr T (2016) Assessment of trace elements levels in patients with Type 2 diabetes using multivariate statistical analysis. J Trace Elem Med Biol 33:114–119 Baskol G, Gumus K, Oner A, Arda H, Karakucuk S (2008) The role of advanced oxidation protein products and total thiols in diabetic retinopathy. Eur J Ophthalmol 18:792–798 Beutler E (1975) Red cell metabolism. A manual of biochemical methods, 2nd edn. Grune and Stratton, New York, pp 112–114 Biswas UK, Kumar A (2012) Study on the changes of carbonic anhydrase activity in insulin resistance and the effect of methylglyoxal. J Pak Med Assoc 62:417–421 Bolkent S, Yanardag R, Bolkent S, Mutlu O (2009) The influence of zinc supplementation on the pancreas of streptozotocin-diabetic rats. Dig Dis Sci 54:2583–2587 Bradley JL, King RH, Muddle JR, Thomas PK (2000) The extracellular matrix of peripheral nerve in diabetic polyneuropathy. Acta Neuropathol 99:539–546 Brzovic´-Sˇaric´ V, Landeka I, Sˇaric´ B, Barberic´ M, Andrijasˇevic´ L, Cerovski B, Orsˇolic´ N, Ðikic´ D (2015) Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients. Mol Vis 21:649–664 Camps J, Marsillach J, Joven J (2009) The paroxanases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci 46:83–106 Chinard FP (1952) Photometric estimation of proline and ornithine. J Biol Chem 199:91–95 Corte ED, Stirpe F (1968) Regulation of xanthine oxidase in rat liver: modifications of the enzyme activity of rat liver supernatant on the storage at 20 degrees. Biochem J 108:349–351 Devarajan A, Shih D, Sirinivasa TR (2014) Inflammation, infection, cancer and all that…the role of paraoxonases. Adv Exp Med Biol 824:33–41 Dische Z, Shettles LB (1948) A specific color reaction of methylpentoses and a spectrophotometric micromethod for their determination. J Biol Chem 175:595–603 Emekli-Alturfan E, Kasikci E, Yarat A (2007) Tissue factor activities of streptozotocin induced diabetic rat tissues and
Biometals the effect of peanut consumption. Diabetes/Metab Res Rev 23:653–658 Furlong CE, Richter RJ, Seidel SL, Motulsky AG (1988) Role of genetic polymorphism of human plasma paraoxonase/ arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon. Am J Hum Genet 43:230–238 Gan KN, Smolen A, Eckerson HW, La Du BN (1991) Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 19:100–106 Gezginci-Oktayoglu S, Basaraner H, Yanardag R, Bolkent S (2009) The effects of combined treatment of antioxidants on the liver injury in STZ diabetic rats. Dig Dis Sci 54:538–546 Gezginci-Oktayoglu S, Sacan O, Yanardag R, Karatug A, Bolkent S (2011) Exendin-4 improves hepatocyte injury by decreasing proliferation through blocking NGF/TrkA in diabetic mice. Peptides 32:223–231 Gezginci-Oktayoglu S, Sacan O, Bolkent S, Ipci Y, Kabasakal L, Sener G, Yanardag R (2014) Chard (Beta vulgaris L. var. cicla) extract ameliorates hyperglycemia by increasing GLUT2 through Akt2 and antioxidant defense in the liver of rats. Acta Histochem 116:32–39 Gopalakrishnan V, Arunakaran J, Aruldhas MM, Srinivasan N (2006) Effects of streptozotocin-induced diabetes mellitus on some bone turnover markers in the vertebrae of ovaryintact and ovariectomized adult rats. Biochem Cell Biol 84:728–736 Hennig B, Meerarani P, Toborek M, McClain CJ (1999) Antioxidant-like properties of zinc in activated endothelial cells. J Am Coll Nutr 18:152–158 Hoshino T, Yamada K, Masuoka K, Tsuboi I, Itoh K, Nonaka K, Oizumi K (1994) Elevated adenosine deaminase activity in the serum of patients with diabetes mellitus. Diabetes Res Clin Pract 25:97–102 Ikeda Y, Suehiro T, Inoue T, Nakauchi Y, Morita T, Arii K, Ito H, Kumon Y, Hashimoto K (1998) Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus. Metabolism 47:598–602 Ingram GI, Hills M (1976) Reference method for the one-stage prothrombin-time test on human blood. Thromb Haemost 36:237–238 Jansen J, Karges W, Rink L (2009) Zinc and diabetes-clinical links and molecular mechanisms. J Nutr Biochem 20:399–417 Kanth VR, Reddy PUM, Raju TN (2008) Attenuation of streptozotocin-induced oxidative stress in hepatic and intestinal tissues of Wistar rat by methanolic-garlic extract. Acta Diabetol 45:243–251 Karatug A, Sacan O, Coskun ZM, Bolkent S, Yanardag R, Turk N, Bolkent S (2012) Regulation of gene expression and biochemical changes in small intestine of newborn diabetic rats by exogenous ghrelin. Peptides 33:101–108 Karatug A, Kaptan A, Bolkent S, Mutlu O, Yanardag R (2013) Alterations in kidney tissue following zinc supplementation to STZ-induced diabetic rats. J Trace Elem Med Biol 27:52–57 Karker H (1964) Method for estimation of serum adenosine deaminase. Scand J Clin Lab Invest 16:570–574
Koksel O, Ozdulger A, Ercil M, Tamer L, Ercan B, Atik U, Cinel L, Cinel L, Kanik A (2004) Effects of N-acetylcysteine on oxidant-antioxidant balance in oleic acid-induced lung injury. Exp Lung Res 30:431–436 Konukoglu D, Serin O, Akcay T, Hatemi H (1999) Relationship between diabetic angiopathic complications and serum total and lipid associated sialic acid concentrations. Med Sci Res 27:53–55 Kumar PA, Haseeb A, Suryanarayana P, Ehtesham NZ, Reddy GB (2005) Elevated expression of aA- and aB-crystallins in streptozotocin-induced diabetic rat. Arch Biochem Biophys 444:77–83 Ledwozyw A, Michalak J, Stepien´ A, Kadziołka A (1986) The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin Chim Acta 155:275–283 Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stantman ER (1990) Determination of carbonyl content in oxidatively modified proteins. In: Packer L, Glazer AN (eds) Methods in enzymology, oxygen radicals in biological systems, vol 186. Academic Press, California, pp 464–478 Lorentz K, Weiss T, Kraas E (1986) Sialic acid in human serum and cerebrospinal fluid. Comparison of methods and reference values. J Clin Chem Clin Biochem 24:189–198 Lowry OH, Rosebrough HJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275 Mackness B, Durrington PN, Abuashia B, Boulton AJM, Mackness MI (2000) Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy. Clin Sci 98:355–363 Maritim AC, Sanders RA, Watkins JB III (2003) Diabetes oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17:24–38 Marjani A, Moradi A, Saeedi M (2005) Plasma lipid peroxidation, zinc and erythrocyte Cu—Zn superoxide dismutase enzyme activity in patients with type 2 diabetes mellitus in Gorgan city (south east of the Caspian Sea). J Med Sci 7:585–590 Marvisi Mi Bartolini L, del Borello P, Brianti M, Marani G, Guariglia A, Cuomo A (2001) Pulmonary function in noninsulin-dependent diabetes mellitus. Respiration 68:268–272 Matsumoto S, Koshiishi I, Inoguchi T, Nawata H, Utsumi H (2003) Confirmation of superoxide generation via xanthine oxidase in streptozotocin-induced diabetic mice. Free Radic Res 37:767–772 Muruganathan U, Srinivasan S, Indumathi D (2013) Antihyperglycemic effect of carvone: effect on the levels of glycoprotein components in streptozotocin-induced diabetic rats. J Acute Disease 2:310–315 Mylorie AA, Colins H, Umbles C, Kyle J (1986) Erythrocyte superoxide dismutase activity and other parameters of copper status in rats ingesting lead acetate. Toxicol Appl Pharmacol 82:512–520 Oberley LW (1988) Free radicals and diabetes. Free Radic Biol Med 5:113–124 Ozsoy N, Can A, Mutlu O, Akev N, Yanardag R (2012) Oral zinc supplementation protects rat kidney tissue from oxidative stress in diabetic rats. Kafkas Univ Vet Fak 18:545–550
123
Biometals Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169 Pari L, Ashokkumar N (2006) Glycoprotein changes in noninsulin dependent diabetic rats: effect of N-benzoyl-Dphenylalanine and metformin. Therapie 61:125–131 Parker KM, England JD, Da Costa J, Hess RL, Goldstein DE (1981) Improved colorimetric assay for glycosylated haemoglobin. Clin Chem 27:669–672 Parui R, Gambhir KK, Cruz I, Hosten AO (1992) Erythrocyte carbonic anhydrase: a major intracellular enzyme to regulate cellular sodium metabolism in chronic renal failure patients with diabetes and hypertension. Biochem Int 26:809–820 Patti ME, Virkama¨ki A, Landaker EJ, Kahn CR, Yki-Ja¨rvinen H (1999) Action of the hexosamine pathway by glucosamine in vivo induces insulin of early postreceptor insulin signaling events in skeletal muscle. Diabetes 48:1562–1571 Pinter E, Peyman JA, Snow K, Jamieson JD, Warshaw JB (1991) Effects of maternal diabetes on fetal rat lung ion transport. Contribution of alveolar and bronchiolar epithelial cells to Na?, K?-ATPase expression. J Clin Invest 87:821–830 Prasad AS (1993) Clinical spectrum of human zinc deficiency. In: Prasad AS (ed) Biochemistry of zinc. Plenum Press, New York, pp 219–258 Prasad AS (2008) Zinc in human health: effect of zinc on immune cells. Mol Med 14:353–357 Prasad AS (2014) Zinc is an antioxidant and anti-inflammatory agent: its role in human health. Front Nutr 1:14 Prasad AS, Bao B, Beck FWJ, Kucuk O, Sarkar FH (2004) Antioxidant effect of zinc in humans. Free Radic Biol Med 37:1182–1190 Punithavathi VR, Prince PSM, Kumar MR, Selvakumari CJ (2011) Protective effects of gallic acid on hepatic lipid peroxide metabolism, glycoprotein components and lipid in streptozotocin-induced type II diabetic wistar rats. J Biochem Mol Toxicol 25:68–76 Rauch U, Nemerson Y (2000) Circulating tissue factor and thrombosis. Curr Opin Hematol 7:273–277 Reedy GK, Enwemeka CS (1996) A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 29:225–229 Ridderstap AS, Bonting SL (1969) Na?-K?-activated ATPase and exocrine pancreatic secretion in vitro. Am J Physiol 217:1721–1727 Rodrigo R, Trujillo S, Bosco C, Orellana M, Thielemann L, Araya J (2002) Changes in (Na ? K)-adenosine triphosphatase activity and ultrastructure of lung and kidney associated with oxidative stress induced by acute ethanol intoxication. Chest 121:589–596 Rutkiewicz J, Go´rski J (1990) On the role of insulin in regulation of adenosine deaminase activity in rat tissues. FEBS Lett 271:79–80 Shah GS, Morofuji Y, Banks WA, Price TO (2013) High glucose-induced mitochondrial respiration and reactive oxygen species in mouse cerebral pericytes is reversed by
123
pharmacological inhibition of mitochondrial carbonic anhydrases: implications for cerebral microvascular disease in diabetes. Biochem Biophys Res Commun 440:354–358 Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106:171–176 Sulaiman GM, Al-Amiery AA, Mohammed AA, Al-Temimi AA (2012) The effect of cherry sticks extract on the levels of glycoproteins in alloxan-induced experimental diabetic mice. Ann Clin Lab Sci 42:34–41 Sundaram R, Naresh R, Shanthi P, Sachdanandam P (2012) Antihyperglycemic effect of iridoid glucoside, isolated from the leaves of Vitex negundo in streptozotocin-induced diabetic rats with special reference to glycoprotein components. Phytomedicine 19:211–216 Tran B, Oliver S, Rosa J, Galassetti P (2012) Aspects of inflammation and oxidative stress in pediatric obesity and type 1 diabetes: An overview of ten years of studies. Exp Diabetes Res. Article ID 683680 Tunali S, Yanardag R (2013) Protective effect of vanadyl sulfate on skin injury in streptozotocin-induced diabetic rats. Hum Exp Toxicol 32:1206–1212 Vallee BL, Falchuk KH (1993) The biochemical basis of zinc physiology. Physiol Rev 73:79–118 Verpoorte JA, Mehta S, Edsall JT (1967) Esterase activities of human carbonic anhydrases B and C. J Biol Chem 242:4221–4229 Wei H, Frenkel K (1991) In vivo formation of oxidized DNA bases in tumor promoter-treated mouse skin. Cancer Res 51:4443–4449 Wendel A (1981) Glutathione peroxidase. Methods Enzymol 77:325–333 Wiese TJ, Dunlap JA, Yorek MA (1997) Effect of L-fucose and D-glucose concentration on L-fucoprotein metabolism in human Hep G2 cells and changes in fucoyltransferase and a-L-fucosidase activity in liver of diabetic rats. Biochim Biophys Acta 1335:61–72 Wijesekara N, Chimienti F, Wheeler MB (2009) Zinc, a regulator of islet function and glucose homeostasis. Diabetes Obes Metab 11:202–214 Winzler RJ (1955) Determination of serum glycoproteins. In: Glick DP (ed) Methods of biochemical analysis. Interscience Publisher Inc, New York, pp 279–311 Witko-Sarsat V, Friedlander M, Capeille´re-Blandin C, NguyenKhoa T, Nguyen AT, Zingraff J, Jungers P, DescampsLatscha B (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304–1313 Wroblewski F (1957) Clinical significance of serum enzyme alterations associated with myocardial infarction. Am Heart J 54:219–224 Yanardag R, Tunali S (2006) Vanadyl sulfate administration protects the streptozotocin-induced oxidative damage to brain tissue in rats. Mol Cell Biochem 286:153–159
